Jean-Pierre Cercueil

Title: Jean-Pierre Cercueil: Innovator in Cancer Treatment

Introduction

Jean-Pierre Cercueil is a notable inventor based in Dijon, France. He has made significant contributions to the field of pharmaceuticals, particularly in cancer treatment. His innovative work has led to the development of a unique formulation that combines Lipiodol with anti-tumor agents.

Latest Patents

Jean-Pierre Cercueil holds a patent for a pharmaceutical composition that includes Lipiodol and a molecule with anti-tumor activity, along with hydroxyethyl starch. This invention is aimed at treating cancer effectively. The composition is designed to contain between 0.004% and 0.2% by weight of idarubicin, between 0.38% and 2.25% by weight of hydroxyethyl starch, and between 60% and 68% by weight of Lipiodol, with water for injection or physiological saline as needed.

Career Highlights

Throughout his career, Jean-Pierre has worked with prominent companies such as Guerbet and Chu De Dijon. His experience in these organizations has allowed him to refine his expertise in pharmaceutical innovations and contribute to advancements in cancer treatment.

Collaborations

Jean-Pierre has collaborated with notable colleagues, including Boris Guiu and Mathieu Boulin. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the field of cancer research.

Conclusion

Jean-Pierre Cercueil's contributions to cancer treatment through his innovative patent demonstrate his commitment to improving patient outcomes. His work continues to inspire advancements in pharmaceutical compositions aimed at combating cancer effectively.